Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 7/20 | 0.75 |
| ▸ | HPGD | P15428 | 2/20 | 0.75 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.75 |
| ▸ | LMNA | P02545 | 1/20 | 0.75 |
| ▸ | PGR | P06401 | 1/20 | 0.75 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.75 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.75 |
| ▸ | MAPT | P10636 | 1/20 | 0.75 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.75 |
| ▸ | CBR1 | P16152 | 1/20 | 0.75 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.75 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.75 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.75 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.75 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11882989 | 0.88 | TTR (0.81) | TTRHPGDNR1I2LMNAPGR | |
| Triclosan SCHEMBL526378 | 0.86 | TTR (1.00) | TTRHPGDNR1I2LMNAPGR | |
| Triclosan SCHEMBL29354475 | 0.86 | TTR (1.00) | TTRHPGDNR1I2LMNAPGR | |
| Triclosan SCHEMBL29367506 | 0.86 | TTR (1.00) | TTRHPGDNR1I2LMNAPGR | |
| SCHEMBL8659315 | 0.86 | TTR (0.55) | TTRHPGDNR1I2LMNAPGR | |
| Triclosan SCHEMBL29356111 | 0.86 | TTR (1.00) | TTRHPGDNR1I2LMNAPGR | |
| Triclosan SCHEMBL3269 | 0.86 | TTR (1.00) | TTRHPGDNR1I2LMNAPGR | |
| SCHEMBL7186092 | 0.85 | TTR (0.75) | TTRHPGDNR1I2LMNAPGR | |
| SCHEMBL240470 | 0.85 | TTR (0.76) | TTRHPGDNR1I2LMNAPGR | |
| Triclosan SCHEMBL8015104 | 0.84 | TTR (0.96) | TTRHPGDNR1I2LMNAPGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2591772-B1 | New coated controlled release active agent carriers | OMYA INT AG (CH) | 2016-05-04 | — | — | EP | claimed |
| EP-2747752-B1 | NEW COATED CONTROLLED RELEASE ACTIVE AGENT CARRIERS | OMYA INT AG (CH) | 2015-10-07 | — | — | EP | claimed |
| US-8894622-B2 | Bottle for packaging liquid that is to be dispensed drop by drop, with antibacterial protection | LABORATOIRES THEA (FR) | 2014-11-25 | — | — | US | claimed |
| EP-2642971-A2 | A SHAVING COMPOSITION FOR PSEUDOFOLLICULITIS BARBAE TREATMENT | NRN Finance APS (DK) | 2013-10-02 | — | — | EP | claimed |
| WO-2012069061-A2 | A SHAVING COMPOSITION FOR PSEUDOFOLLICULITIS BARBAE TREATMENT | NRN FINANCE APS (DK) | 2012-05-31 | — | — | WO | claimed |
| US-7632348-B2 | cement; expanded polymeric particles with specific particle size, bulk density and aspect ratio, containing antimicorbial agents such as Triclosan, zinc carboxylate; boric acids; sodium dichromate etc. used to make concrete masonry units, construction panels, dining tables, counter surfaces etc. | NOVA CHEMICALS INC. (US) | 2009-12-15 | — | — | US | claimed |
| EP-2001818-A2 | LIGHTWEIGHT CONCRETE COMPOSITIONS CONTAINING ANTIMICROBIAL AGENTS | Nova Chemicals Inc. (US) | 2008-12-17 | — | — | EP | claimed |
| EP-1585751-A4 | PEPTIDE DEFORMYLASE ACTIVATED PRODRUGS | CELMED ONCOLOGY USA INC (CA) | 2008-08-13 | — | — | EP | claimed |
| WO-2007111859-A2 | LIGHTWEIGHT CONCRETE COMPOSITIONS CONTAINING ANTIMICROBIAL AGENTS | NOVA CHEMICALS INC. (US) | 2007-10-04 | — | — | WO | claimed |
| US-20070027224-A1 | Lightweight concrete compositions containing antimicrobial agents | SYNTHEON INC. | 2007-02-01 | — | — | US | claimed |
| US-20040236096-A1 | Peptide deformylase activated prodrugs | NEWBIOTICS, INC. | 2004-11-25 | — | — | US | claimed |
| WO-2004043400-A2 | PEPTIDE DEFORMYLASE ACTIVATED PRODRUGS | CELMED ONCOLOGY (USA), INC. (CA) | 2004-05-27 | — | — | WO | claimed |
| EP-1263762-A4 | ANTI-INFECTIVE ECTATM | NEWBIOTICS INC (US) | 2003-04-02 | — | — | EP | claimed |
| EP-1263762-A1 | ANTI-INFECTIVE ECTATM | Newbiotics Inc. (US) | 2002-12-11 | — | — | EP | claimed |
| WO-2001064687-A1 | ANTI-INFECTIVE ECTA?TM¿ | NEWBIOTICS, INC. (US) | 2001-09-07 | — | — | WO | claimed |
| US-6266951-B1 | Cut resistant yarn and apparel | WHIZARD PROTECTIVE WEAR CORP. | 2001-07-31 | — | — | US | claimed |
| US-6260344-B1 | CORE OF STAINLESS STEEL, GLASS FIBERS, OR POLYPHENYLENE TEREPHTHALAMIDE WRAPPED WITH MICROBIOCIDE TREATED ACRYLIC FIBER; PROTECTIVE CLOTHING, GLOVES | WHIZARD PROTECTIVE WEAR CORP. | 2001-07-17 | — | — | US | claimed |
| US-6045785-A | COMPRISING A STEROL SULFATE, ALUMINUM CHLOROHYDRATE, AND AN ESTERASE INHIBITOR, A BACTERICIDAL AGENT, OR A BACTERIOSTATIC AGENT | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2000-04-04 | — | — | US | claimed |
| WO-1999035315-A1 | CUT RESISTANT YARN AND APPAREL | WHIZARD PROTECTIVE WEAR CORP. (US) | 1999-07-15 | — | — | WO | claimed |
| WO-1996015107-A1 | DITHIOCARBAMATE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 1996-05-23 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040236096-A1 | Peptide deformylase activated prodrugs | DNPEP, DPEP1, PEPD | TTR 4046/4885HPGD 850/4885NR1I2 3302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.